In USA the FDA has deemed that Oral Devices can only be provided by Health professionals ie by prescription to ensure patient safety, efficacy of treatment. Only the aveoTSD tongue stabilizing device can be prescribed also by Primary health care physicians as no specialist fitting is needed.

In most other countries, Canada, Japan, Australia, NZ, EU , Hongkong etc the device is available via Pharmacy, also, and other Health distribution channels. As a class 1 medical device it can thus reach the sufferers in numbers that can meet health disparities inequalities requirements.

The aveoTSD if indeed can reach the sufferers in numbers, then as the unit has a diagnostics aid function in useage and by instructions, users will be able to make contact for further medical consultation.

The aveoTSD will support the increasing sleep Disordered Breathing [SDB] awareness and as Health consequences become more understood including the undiagnosed obstructive sleep apnoea [OSA]. With SNORING being a health Warning, It is foreseeable that PRIMARY HEALTH CARE will play a significant if not major role re SDB.